EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Current global vitamin and cofactor prescribing practices for primary mitochondrial diseases: Results of a European reference network survey

Julia Neugebauer iD, Karit Reinson, Marcello Bellusci, Julien H Park, Omar Hikmat, Enrico Bertini, Manuel Schiff, MetabERN PM‐MD Consortium authors, Shamima Rahman iD

Journal of Inherited Metabolic Disease · 2025

DOI: 10.1002/jimd.12805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2025. Verfasst von Julia Neugebauer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Gastroenterology, Nephrology and Metabolic Medicine, Charité - Universitaetsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Mitochondrial Diseases, Vitamins, Practice Patterns, Physicians'. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary mitochondrial diseases (PMD) account for a group of approximately 400 different genetic disorders with diverse clinical presentations and pathomechanisms. Although each individual disorder is rare, collectively they represent one of the largest groups in the field of inherited metabolic disorders. The complexity of PMD results in a continued lack of therapeutic options, necessitating a predominantly symptomatic treatment approach for affected patients. While a subset of diseases responds exceptionally well to treatment with specific vitamins or cofactors, for most PMD systematic reviews were not able to show significant benefit. This is in discrepancy to their continued frequent use among specialists. To gain further insight into the current clinical practice of vitamin and cofactor supplementation among clinicians treating children and adults affected by PMD, we conducted a worldwide cross‐sectional questionnaire study exploring the choice of substances and the specific diseases where they are applied. To our knowledge, this is the first global study exploring this topic and featuring a high response rate from paediatricians. The vast majority (95%, 106/112) of responding specialists recommended the use of vitamins and cofactors, either in an agnostic approach irrespective of the specific PMD or directed to the treatment of specific diseases or phenotypes. Our study highlights significant regional and specialty‐specific differences in supplementation practices. We provide some preliminary insights into specialist‐based opinions regarding the use of vitamins and cofactors in PMD and highlight the need for more rigorous clinical and preclinical investigations and/or clear consensus statements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitochondrial DiseasesVitaminsPractice Patterns, Physicians'HumansCross-Sectional StudiesSurveys and QuestionnairesEuropeDietary SupplementsCoenzymesChildAdult

Stichwörter der Autor:innen

cofactorscross sectional studyinherited metabolic diseaseprimary mitochondrial diseasesurveytreatmentvitamins

Substanzen

VitaminsCoenzymes

Autor:innen und Institutionen

  • Department of Paediatric Gastroenterology, Nephrology and Metabolic Medicine, Charité - Universitaetsmedizin Berlin, Berlin, Germany.
  • Center for Chronically Sick Children, Charité - Universitaetsmedizin Berlin, Berlin, Germany.
  • Department of Clinical Genetics, Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia.
  • Department of Genetics and Personalized Medicine, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
  • Reference Center for Inherited Metabolic Disorders MetabERN, Mitochondrial Disorders Research Group (imas12) '12 de Octubre' University Hospital, Madrid, Spain.
  • Department of General Paediatrics, University Hospital Muenster, Muenster, Germany.

ORCID-Profile: Julia Neugebauer, Shamima Rahman

Zitieren

APA

Neugebauer, J., Reinson, K., Bellusci, M., Park, J. H., Hikmat, O., Bertini, E., Schiff, M., MetabERN PM‐MD Consortium authors, & Rahman, S. (2025). Current global vitamin and cofactor prescribing practices for primary mitochondrial diseases: Results of a European reference network survey. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12805

Vancouver

Neugebauer J, Reinson K, Bellusci M, Park JH, Hikmat O, Bertini E, et al. Current global vitamin and cofactor prescribing practices for primary mitochondrial diseases: Results of a European reference network survey. Journal of Inherited Metabolic Disease. 2025. doi:10.1002/jimd.12805

BibTeX
@article{Neugebauer2025,
  author = {Neugebauer, Julia and Reinson, Karit and Bellusci, Marcello and Park, Julien H and Hikmat, Omar and Bertini, Enrico and Schiff, Manuel and MetabERN PM‐MD Consortium authors, MetabERN PM‐MD Consortium authors and Rahman, Shamima},
  title = {Current global vitamin and cofactor prescribing practices for primary mitochondrial diseases: Results of a European reference network survey},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2025},
  doi = {10.1002/jimd.12805}
}
Kostenlos starten →